Evidence map›Paper›PMID 36212156›Full record

ArticleFrontiers in genetics2022

The potential role of integrin alpha 6 in human mesenchymal stem cells.

Mohammed Al-Obaide, Albi Ishmakej, Christina Brown, Matteo Mazzella, Patrina Agosta, Mick Perez-Cruet, G Rasul Chaudhry

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Vitamin D Reprograms Non-Coding RNA Networks to Block Zika Virus in Human Macrophages.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  3. Integrin-Alpha-6+ Cells Are Responsible for Blastema Formation During Oral Siphon Regeneration in Ciona robusta.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Characteristics of mJournal of Cancer · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mohammed Al-ObaideDepartment of Biological Sciences, Oakland University, Rochester, MI, United States.
Albi IshmakejDepartment of Biological Sciences, Oakland University, Rochester, MI, United States.
Christina BrownDepartment of Biological Sciences, Oakland University, Rochester, MI, United States.
Matteo MazzellaDepartment of Biological Sciences, Oakland University, Rochester, MI, United States.
Patrina AgostaAscension Providence Hospital, Southfield, MI, United States.
Mick Perez-CruetOU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI, United States.
G Rasul ChaudhryDepartment of Biological Sciences, Oakland University, Rochester, MI, United States.
Oakland University · USAscension Providence Hospital · USBeaumont Health · US

Funding

Efficacy of NSCs in an EAE model of MSR16NS129748 · NINDS · OAKLAND UNIVERSITY · PI CHAUDHRY, G. RASUL · 2022 to 2025
$600k
NINDS NIH HHS R16 NS129748
6 · The paper itself

Abstract

Human mesenchymal stem cells (MSCs) are isolated from various adult and perinatal tissues. Although mesenchymal stem cells from multiple sources exhibit similar morphology and cell surface markers, they differ in their properties. In this study, we determined that the expression of integrin alpha 6 (

Indexed as

integrin alpha 6integrin alpha 6-antisense 1lncRNAmesenchymal stem cellspromotersself-renewal

Identifiers

PMID36212156
PMCPMC9535380
OpenAlexW4296044534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.